Cargando…

Determinants of imminent fracture risk in postmenopausal women with osteoporosis

SUMMARY: In elderly women with osteoporosis, prior fracture, low BMD, impaired physical functioning, poorer general health, and recent falls were all direct predictors of imminent (in next year) fracture risk. Prior fracture, older age, worse health, impaired cognitive functioning, and recent falls...

Descripción completa

Detalles Bibliográficos
Autores principales:	Barron, R. L., Oster, G., Grauer, A., Crittenden, D. B., Weycker, D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer London 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7560920/ https://www.ncbi.nlm.nih.gov/pubmed/32613410 http://dx.doi.org/10.1007/s00198-020-05294-3

Ejemplares similares

Predictors of Imminent Risk of Nonvertebral Fracture in Older, High‐Risk Women: The Framingham Osteoporosis Study
por: Hannan, Marian T, et al.
Publicado: (2019)

Predictors of near-term fracture in osteoporotic women aged ≥65 years, based on data from the study of osteoporotic fractures
por: Weycker, D., et al.
Publicado: (2017)

Predicting imminent risk for fracture in patients aged 50 or older with osteoporosis using US claims data
por: Bonafede, M., et al.
Publicado: (2016)

Predictors of imminent risk of fracture in Medicare-enrolled men and women
por: Yusuf, Akeem A., et al.
Publicado: (2020)

Osteoporosis – An Imminent Ethical and Legal Debacle?
por: Pai, Satvik N, et al.
Publicado: (2023)

Effects of risedronate on fracture risk in postmenopausal women with osteopenia
por: Siris, E. S., et al.
Publicado: (2007)

Osteoporosis and fracture risk assessment: improving outcomes in postmenopausal women
por: Perez, Mariana Ortega, et al.
Publicado: (2023)

In community-dwelling women frailty is associated with imminent risk of osteoporotic fractures
por: Bartosch, P., et al.
Publicado: (2021)

Hospitalizations for osteoporosis-related fractures: Economic costs and clinical outcomes
por: Weycker, Derek, et al.
Publicado: (2016)

Progress in osteoporosis and fracture prevention: focus on postmenopausal women
por: Saag, Kenneth G, et al.
Publicado: (2009)

Abaloparatide effect on forearm bone mineral density and wrist fracture risk in postmenopausal women with osteoporosis
por: Watts, N.B., et al.
Publicado: (2019)

Geography of Fracture Incidence in Postmenopausal Women with Osteoporosis Treated with Abaloparatide
por: McClung, Michael R., et al.
Publicado: (2017)

Infections in postmenopausal women with osteoporosis treated with denosumab or placebo: coincidence or causal association?
por: Watts, N. B., et al.
Publicado: (2011)

Osteoporosis, vertebral fractures and metabolic syndrome in postmenopausal women
por: El Maghraoui, Abdellah, et al.
Publicado: (2014)

Correction to: Abaloparatide effect on forearm bone mineral density and wrist fracture risk in postmenopausal women with osteoporosis
por: Watts, N. B., et al.
Publicado: (2020)

Correction to: Abaloparatide effect on forearm bone mineral density and wrist fracture risk in postmenopausal women with osteoporosis
por: Watts, N. B., et al.
Publicado: (2020)

10-Year Fracture Risk in Postmenopausal Women with Osteopenia and Osteoporosis in South Korea
por: Baek, Yeon-Hee, et al.
Publicado: (2021)

Strontium ranelate reduces the risk of vertebral fracture in young postmenopausal women with severe osteoporosis
por: Roux, C, et al.
Publicado: (2008)

The Effect of 1 Year of Romosozumab on the Incidence of Clinical Vertebral Fractures in Postmenopausal Women With Osteoporosis: Results From the FRAME Study
por: Geusens, Piet, et al.
Publicado: (2019)

Risk Factors for Osteoporosis in Postmenopausal Women
por: Bijelic, Radojka, et al.
Publicado: (2017)

Correction to: Geography of Fracture Incidence in Postmenopausal Women with Osteoporosis Treated with Abaloparatide
por: McClung, Michael R., et al.
Publicado: (2018)

Teriparatide treatment patterns in osteoporosis and subsequent fracture events: a US claims analysis
por: Bonafede, M. M., et al.
Publicado: (2015)

Effect of Abaloparatide vs Alendronate on Fracture Risk Reduction in Postmenopausal Women With Osteoporosis
por: Leder, Benjamin Z, et al.
Publicado: (2019)

Effects of long-term strontium ranelate treatment on vertebral fracture risk in postmenopausal women with osteoporosis
por: Meunier, P. J., et al.
Publicado: (2009)

Which treatment to prevent an imminent fracture?
por: Laura, Iconaru, et al.
Publicado: (2021)

Cost-effectiveness of romosozumab for the treatment of postmenopausal women with severe osteoporosis at high risk of fracture in Sweden
por: Söreskog, E., et al.
Publicado: (2021)

ERRATUM for “Effect of Abaloparatide vs Alendronate on Fracture Risk Reduction in Postmenopausal Women With Osteoporosis”
Publicado: (2020)

Risk of imminent fracture following a previous fracture in a Swedish database study
por: Banefelt, J., et al.
Publicado: (2019)

Muscle composition and the imminent mortality risk after hip fracture
por: Wang, Ling, et al.
Publicado: (2022)

Primary osteoporosis in postmenopausal women
por: Ji, Meng-Xia, et al.
Publicado: (2015)

Analysis of Related Factors of Brittle Hip Fracture in Postmenopausal Women with Osteoporosis
por: Zhuang, Hua‐feng, et al.
Publicado: (2020)

Risedronate’s Role in Reducing Hip Fracture in Postmenopausal Women with Established Osteoporosis
por: Gates, Brian J., et al.
Publicado: (2012)

Effect of medications and epidural steroid injections on fractures in postmenopausal women with osteoporosis
por: Kim, Minsoo, et al.
Publicado: (2019)

Abaloparatide for risk reduction of nonvertebral and vertebral fractures in postmenopausal women with osteoporosis: a network meta-analysis
por: Reginster, J. -Y., et al.
Publicado: (2019)

Anabolic treatments for osteoporosis in postmenopausal women
por: Hassan, Neelam, et al.
Publicado: (2021)

Dietary Patterns and Osteoporosis Risk in Postmenopausal Korean Women
por: Park, Seon-Joo, et al.
Publicado: (2012)

Regular Exercise Decreases the Risk of Osteoporosis in Postmenopausal Women
por: Chang, Chu-Fen, et al.
Publicado: (2022)

Treating postmenopausal osteoporosis in women at increased risk of fracture – critical appraisal of bazedoxifene: a review
por: Vestergaard, Peter, et al.
Publicado: (2010)

Comorbidity indices for clinical trials: adaptation of two existing indices for use with the FREEDOM trial in women with postmenopausal osteoporosis
por: Silverman, S. L., et al.
Publicado: (2015)

History of Previous Fracture and Imminent Fracture Risk in Swedish Women Aged 55 to 90 Years Presenting With a Fragility Fracture
por: Toth, Emese, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_vsdqe9nb07fd5uhpt6craivg8q